Cargando…

Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review

Graves’ disease is the most common cause of hyperthyroidism. Antithyroid drugs, radioiodine ablation, and surgery are the main treatments. Research has demonstrated that adding thyroxine to antithyroid therapy can improve the remission rate, and many similar studies have been conducted subsequently....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jun, Bai, Litao, Wei, Fan, Wei, Maoying, Xiao, Yao, Yan, Weitian, Wei, Junping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868565/ https://www.ncbi.nlm.nih.gov/pubmed/33569041 http://dx.doi.org/10.3389/fendo.2020.560157

Ejemplares similares

Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves’ Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method
por: Theiler-Schwetz, Verena, et al.
Publicado: (2022)

Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
por: Li, Jun, et al.
Publicado: (2019)

Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy
por: Wei, Maoying, et al.
Publicado: (2023)

Thyroxine changes in COVID-19 pandemic: A systematic review and meta-analysis
por: Li, Ziqi, et al.
Publicado: (2023)

Preoperative preparation for Graves’ disease
por: Xu, Tianfeng, et al.
Publicado: (2023)

Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease
por: Yao, Qiuming, et al.
Publicado: (2019)

Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption
por: Trimboli, Pierpaolo, et al.
Publicado: (2018)

Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial
por: Wu, Rui, et al.
Publicado: (2020)

Defective Response of Natural Killer Activity to Thyroxine in Graves’ Disease
por: Lee, Myung-Shik, et al.
Publicado: (1990)

Graves’ Disease and Rheumatoid Arthritis: A Bidirectional Mendelian Randomization Study
por: Wu, Dide, et al.
Publicado: (2021)

Intestinal microbiota changes in Graves’ disease: a prospective clinical study
por: Yan, Hui-xian, et al.
Publicado: (2020)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Effects of Selenium Supplementation on Graves' Disease: A Systematic Review and Meta-Analysis
por: Zheng, Huijuan, et al.
Publicado: (2018)

Thyroxine Supplementation in Pregnant Women After Thyroidectomy for Thyroid Cancer and Neonatal Birth Weight
por: Ding, Zheng, et al.
Publicado: (2021)

Application of oral inorganic iodine in the treatment of Graves’ disease
por: Huang, Yixuan, et al.
Publicado: (2023)

The Association Between COVID-19 and Thyroxine Levels: A Meta-Analysis
por: Chen, Yiru, et al.
Publicado: (2022)

Thyroxine Replacement for Subfertile Females With Subclinical Hypothyroidism and Autoimmune Thyroiditis: A Systematic Review
por: Myneni, Revathi, et al.
Publicado: (2021)

Effect of Thyroxine and Thyrotropin on Bone Mineral Density in Postmenopausal Women: A Systematic Review
por: Poudel, Prakar, et al.
Publicado: (2022)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy
por: Wang, Yan, et al.
Publicado: (2022)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Free Thyroxine Levels are Associated with Cold Induced Thermogenesis in Healthy Euthyroid Individuals
por: Maushart, Claudia Irene, et al.
Publicado: (2021)

Daily requirement of softgel thyroxine is independent from gastric juice pH
por: Virili, Camilla, et al.
Publicado: (2022)

Compelling Evidence Linking CD40 Gene With Graves’ Disease in the Chinese Han Population
por: Jiang, He, et al.
Publicado: (2021)

Identification of Novel Environmental Substances Relevant to Pediatric Graves’ Disease
por: Xia, Qin, et al.
Publicado: (2021)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Graves‘ disease following vaccination against SARS-CoV-2: A systematic review of the reported cases
por: Triantafyllidis, Konstantinos Katsikas, et al.
Publicado: (2022)

Therapeutic Potential of Targeting Periostin in the Treatment of Graves’ Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2022)

Editorial: News in Graves’ orbitopathy: patients management and treatments
por: Lanzolla, Giulia, et al.
Publicado: (2023)

Identifying Non-Linear Association Between Maternal Free Thyroxine and Risk of Preterm Delivery by a Machine Learning Model
por: Zhou, Yulai, et al.
Publicado: (2022)

Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer
por: Zhou, Ruo-Yun, et al.
Publicado: (2023)

Asymmetric Graves’ Orbitopathy
por: Panagiotou, Grigorios, et al.
Publicado: (2020)

Mechanisms That Underly T Cell Immunity in Graves’ Orbitopathy
por: Fang, Sijie, et al.
Publicado: (2021)

Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
por: Boddu, Neeraja, et al.
Publicado: (2017)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
por: Villagelin, Danilo, et al.
Publicado: (2019)

Graves’ disease as a driver of depression: a mechanistic insight
por: Song, Yifei, et al.
Publicado: (2023)

Comparison Among Two Liquid Formulations of L-thyroxine in the Treatment of Congenital Hypothyroidism in the First Month of Life: A Pilot Study
por: Tuli, Gerdi, et al.
Publicado: (2022)

The Association Between Foxp3 Polymorphisms and Risk of Graves' Disease: A Systematic Review and Meta-Analysis of Observational Studies
por: Li, Han-ning, et al.
Publicado: (2020)

Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population
por: Liu, Huan-Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jqtn1k047audhlpbg2q9hvn5cr